Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.64
Bid: 41.48
Ask: 41.54
Change: 0.74 (1.81%)
Spread: 0.06 (0.145%)
Open: 42.08
High: 42.08
Low: 41.20
Prev. Close: 40.90
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Jul 2019 07:00

RNS Number : 1070E
Assura PLC
02 July 2019
 

2 July 2019

Assura plc

 

Trading Update

For the first quarter to 30 June 2019

 

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

 

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of £17 million which was above book value.

 

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial £92 million.

 

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

 

"We remain confident in our outlook for the full year and in our longer-term prospects."

 

Developments and strategic acquisitions strengthen market-leading portfolio

· One development completed (Darley Dale) at a cost of £2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of £58 million.

· Two acquisitions completed in the period at a cost of £5.5 million.

· 12 disposals completed for £17 million cash consideration at a small premium to book value.

 

GPI acquisition expands pipeline

· Current portfolio of 554 properties.

· Immediate development pipeline of £77 million.

· Immediate acquisitions pipeline increased to £64 million, compared with £41 million at March 2019.

· Total immediate pipeline value, including on site developments, of £199 million up from £142 million at the year end.

 

Active portfolio management delivering value

· Six lease re-gears agreed on £0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

· Annualised rent roll at £102.1 million post disposals.

 

Strong financial position

· As at 30 June 2019 gross debt £730 million with undrawn facilities of £230 million plus cash balance of £47.5 million.

 

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFOOrla Ball, Company SecretaryDavid Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLRDEILIIA
Date   Source Headline
13th Jan 20207:00 amRNSScrip dividend declaration
13th Jan 20207:00 amRNSTrading update
6th Jan 202012:11 pmRNSNotification of Major Interests in Shares
19th Dec 20191:43 pmRNSDirector/PDMR Shareholding
19th Dec 201910:15 amRNSScrip Calculation Price
10th Dec 201911:01 amRNSNotification of Major Interests in Shares
5th Dec 20199:02 amRNSNotice of Dividend
12th Nov 20197:00 amRNSInterim Results 2019
1st Nov 20199:48 amRNSDirector Declaration
18th Oct 20194:31 pmRNSNotification of Major Interests in Shares
17th Oct 20199:46 amRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSScrip Dividend Declaration
3rd Oct 20197:00 amRNSTrading Update
19th Sep 201910:19 amRNSScrip Calculation Price
9th Sep 201911:25 amRNSPDMR Notification
5th Sep 20197:00 amRNSNotice of Dividend
21st Aug 20194:27 pmRNSNotification of Major Interests in Shares
13th Aug 20194:10 pmRNSExercise of Nil Cost Options under PSP
9th Aug 20192:40 pmRNSAdditional Listing
8th Aug 20197:00 amRNSNote issuance
17th Jul 20193:07 pmRNSPersons Discharging Managerial Responsibilities
15th Jul 20197:00 amRNSScrip Dividend Declaration
3rd Jul 20194:03 pmRNSPDMR Notification
2nd Jul 20192:41 pmRNSResult of AGM
2nd Jul 20197:00 amRNSTrading Update
20th Jun 201911:45 amRNSScrip Calculation Price
10th Jun 20193:46 pmRNSNotification of Major Interests in Shares
6th Jun 20197:00 amRNSNotice of Dividend
5th Jun 20199:00 amRNSNotification of Major Interests in Shares
4th Jun 20193:10 pmRNSPDMR Notification
30th May 20197:00 amRNSAnnual Report and Notice of AGM
30th May 20197:00 amRNSAppointment of Non-Executive Director
21st May 20197:00 amRNSAssura Full Year Results
20th May 201910:41 amRNSDirectorate Change
17th Apr 20192:35 pmRNSPersons Discharging Managerial Responsibilities
15th Apr 20197:00 amRNSScrip Dividend Declaration
21st Mar 201912:13 pmRNSScrip Calculation Price
7th Mar 20192:23 pmRNSNotice of Dividend
14th Feb 20199:36 amRNSIssue of Consideration Shares
22nd Jan 20197:00 amRNSTrading Update
14th Jan 20197:00 amRNSScrip dividend declaration
20th Dec 201810:17 amRNSScrip Calculation Price
6th Dec 20189:30 amRNSNotice of dividend
22nd Nov 20187:00 amRNSInterim Results 2018
1st Nov 20187:00 amRNSTotal Voting Rights
15th Oct 20187:00 amRNSScrip Dividend Declaration
5th Oct 20187:00 amRNSAcquisition update
1st Oct 20187:00 amRNSTrading Update
28th Sep 20184:58 pmRNSNotification of Major Interests in Shares
20th Sep 201810:26 amRNSScrip Calculation Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.